Latest News and Press Releases

Ghent, Belgium, 4th February 2025 Ardena, a specialist pharmaceutical Contract Development and Manufacturing Organization (CDMO) and bioanalytical Contract Research Organization (CRO) with facilities...

Ardena acquires Catalent's Somerset, NJ facility, expanding its US presence and boosting advanced oral drug product manufacturing capabilities.

Kuehn Law investigates potential claims related to proposed mergers of NGM, CTLT, SDPI, and HRT. Shareholders urged to contact for more info.

MONSEY, N.Y., Feb. 07, 2024 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP is investigating whether Catalent, Inc. (NYSE: CTLT) (“Catalent”) has violated federal securities laws based...

NEW YORK, Feb. 06, 2024 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating potential claims related to the below-listed proposed mergers. Kuehn Law may seek...

We are investigating the fairness of the sale of Catalent to Novo Holdings for $63.50 per share in cash.

NEW YORK, Sept. 27, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Catalent, Inc. (NYSE:...

NEW YORK, Aug. 21, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Catalent, Inc. (NYSE:...

BOSTON, July 25, 2023 (GLOBE NEWSWIRE) -- Block & Leviton is investigating Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) for potential securities law violations. Investors who have lost money...

Covina, June 14, 2023 (GLOBE NEWSWIRE) -- What is Biologics CDMO? How big is the Biologics CDMO Market? Report Overview: Biologics are group of medicines which includes, immune modulators,...